Concomitant Dietary Supplement and Prescription Medication Use Is Prevalent among US Adults with Doctor-Informed Medical Conditions

Journal of the Academy of Nutrition and Dietetics

Volumn 114, Issue 11, 2014, Pages 1784-1790.e2

  Farina, Emily K ^a   Austin, Krista G ^a   Lieberman, Harris R ^b  

^a OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^b U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

Author keywords

Chronic disease; Dietary supplements; Interactions; Medical conditions; Prescription medications

Indexed keywords

ANTACID AGENT; CARDIOVASCULAR AGENT; HORMONE; PRESCRIPTION DRUG; VITAMIN;

ADULT; AGED; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; FEMALE; HEALTH CARE SURVEY; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTACIDS; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HEALTH CARE SURVEYS; HEALTH SURVEYS; HORMONES; HUMANS; MALE; MIDDLE AGED; PRESCRIPTION DRUGS; UNITED STATES; VITAMINS; YOUNG ADULT;

EID: 84908482030     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2014.01.016     Document Type: Article

References (30)

1. Gahche J., Bailey R., Burt V., et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief 2011, 61:1-8.
2. Bailey R.L., Gahche J.J., Lentino C.V., et al. Dietary supplement use in the United States, 2003-2006. JNutr 2011, 141(2):261-266.
3. Sood A., Sood R., Brinker F.J., Mann R., Loehrer L.L., Wahner-Roedler D.L. Potential for interactions between dietary supplements and prescription medications. Am J Med 2008, 121(3):207-211.
4. Lee A.H., Ingraham S.E., Kopp M., Foraida M.I., Jazieh A.R. The incidenceof potential interactions between dietary supplements andprescription medications in cancer patients at a VeteransAdministration Hospital. Am J Clin Oncol 2006, 29(2):178-182.
5. Loya A.M., Gonzalez-Stuart A., Rivera J.O. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: A descriptive, questionnaire-based study. Drugs Aging 2009, 26(5):423-436.
6. Peng C.C., Glassman P.A., Trilli L.E., Hayes-Hunter J., Good C.B. Incidence and severity of potential drug-dietary supplement interactions in primary care patients: An exploratory study of 2 outpatient practices. Arch Intern Med 2004, 164(6):630-636.
7. Jang E.H., Park Y.C., Chung W.G. Effects of dietary supplements on induction and inhibition of cytochrome P450s protein expression in rats. Food Chem Toxicol 2004, 42(11):1749-1756.
8. Harris R.Z., Jang G.R., Tsunoda S. Dietary effects on drug metabolism and transport. Clin Pharmacokinet 2003, 42(13):1071-1088.
9. Tsai H.H., Lin H.W., Simon Pickard A., Tsai H.Y., Mahady G.B. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: A systematic literature review. Int J Clin Pract 2012, 66(11):1056-1078.
10. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998, 280(18):1569-1575.
11. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002, 287(3):337-344.
12. Qato D.M., Alexander G.C., Conti R.M., Johnson M., Schumm P., Lindau S.T. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008, 300(24):2867-2878.
13. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Accessed November 29,2012. http://www.cdc.gov/nchs/nhanes.htm.
14. Centers for Disease Control and Prevention. Dietary supplement use 30 day: Individual dietary supplements (DSQIDS_E). Accessed December 2,2013. http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/DSQIDS_E.htm#Interview_Setting_and_Mode_of_Administration.
15. Centers for Disease Control and Prevention. Dietary supplements and prescription medication-DSQ. Accessed December 2,2013. http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/DSQ_e_eng.pdf.
16. Radimer K., Bindewald B., Hughes J., Ervin B., Swanson C., Picciano M.F. Dietary supplement use by US adults: Data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004, 160(4):339-349.
17. National Health and Nutrition Examination Survey: 1988-2010 datadocumentation, codebook, and frequencies, prescription medications - drug information (RXQ_Drug). Accessed December 2, 2013. http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/RXQ_DRUG.htm.
18. Centers for Disease Control and Prevention. Key concepts about specifying sampling parameters in NHANES Using SUDAAN, SAS Survey Procedures, and Stata. Accessed December 12,2012. http://www.cdc.gov/nchs/tutorials/NHANES/SurveyDesign/SampleDesign/Info2.htm.
19. Centers for Disease Control and Prevention. Continuous NHANES Web tutorial: Age standardization: Key concepts about population counts. Accessed September 10,2013. http://www.cdc.gov/nchs/tutorials/NHANES/NHANESAnalyses/AgeStandardization/Info2.htm.
20. Centers for Disease Control and Prevention. NHANES response rates and population totals. Accessed February 17,2014. http://www.cdc.gov/nchs/nhanes/response_rates_CPS.htm.
21. Gardiner P., Graham R.E., Legedza A.T., Eisenberg D.M., Phillips R.S. Factors associated with dietary supplement use among prescription medication users. Arch Intern Med 2006, 166(18):1968-1974.
22. Barnes P.M., Bloom B., Nahin R.L. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008, (12):1-23.
23. Bailey R.L., Gahche J.J., Miller P.E., Thomas P.R., Dwyer J.T. Why US adultsuse dietary supplements. JAMA Intern Med 2013, 173(5):355-361.
24. Jong M.C., van de Vijver L., Busch M., Fritsma J., Seldenrijk R. Integrationof complementary and alternative medicine in primarycare:What do patients want?. Patient Educ Couns 2012, 89(3):417-422.
25. Davis E.L., Oh B., Butow P.N., Mullan B.A., Clarke S. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: A systematic review. Oncologist 2012, 17(11):1475-1481.
26. Thomson P., Jones J., Evans J.M., Leslie S.L. Factors influencing the use of complementary and alternative medicine and whether patients inform their primary care physician. Complement Ther Med 2012, 20(1-2):45-53.
27. de Lima Toccafondo Vieira M., Huang S.M. Botanical-drug interactions: A scientific perspective. Planta Med 2012, 78(13):1400-1415.
28. Hermann R., von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med 2012, 78(13):1458-1477.
29. Izzo A.A., Ernst E. Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs 2009, 69(13):1777-1798.
30. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies). Natl Toxicol Program Tech Rep Ser 2013, (578):1-183.